₹8,513 Cr
27.14
₹314 Cr
As on 13-Aug-2024 IST
₹-8.24
•
-4.20%
₹196.29
₹197.50
₹198.45
₹186.60
13,25,591
₹97.45 - 212.98
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Marksans Pharma
| 16.73 | -0.59 | 18.08 | 59.09 | 33.97 | 61.72 | 17.77 |
|
BSE Healthcare
| 30.05 | 6.86 | 18.26 | 46.79 | 16.31 | 26.45 | 12.81 |
|
BSE Small Cap
| 24.81 | -1.39 | 17.32 | 50.92 | 26.42 | 33.21 | 18.27 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Marksans Pharma
| 176.57 | -3.16 | -1.31 | 253.64 | -40.78 | -30.29 | 0.25 |
|
BSE Small Cap
| 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 | 59.64 |
|
BSE Healthcare
| 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
No Review & Analysis are available.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Marksans Pharma Ltd stood at ₹ 2,681 Cr as on 31-Mar-24
The share price of Marksans Pharma Ltd is ₹188.05 (NSE) and ₹187.85 (BSE) as of 13-Aug-2024 IST. Marksans Pharma Ltd has given a return of 33.97% in the last 3 years.
Marksans Pharma Ltd has a market capitalisation of ₹ 8,513 Cr as on 13-Aug-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Marksans Pharma Ltd is 4.12 times as on 13-Aug-2024, a 858% premium to its peers’ median range of 0.43 times.
The P/E ratio of Marksans Pharma Ltd is 27.14 times as on 13-Aug-2024.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Marksans Pharma Ltd and enter the required number of quantities and click on buy to purchase the shares of Marksans Pharma Ltd.
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
The promoter of Marksans Pharma Ltd is MARK SALDANHA. MARK SALDANHA owns 43.8 per cent of the total equity. The chairman of the company is Mark Saldanha , and the managing director is Mark Saldanha..
There is no promoter pledging in Marksans Pharma Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
3,027
|
|
|
452
|
|
|
289
|
|
|
58
|
| Marksans Pharma Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
15.92
|
|
Operating margin(%)
|
17.65
|
|
Net Margin(%)
|
14.13
|
|
Dividend yield(%)
|
0.32
|
Yes, TTM profit after tax of Marksans Pharma Ltd was ₹314 Cr.
No Review & Analysis are available.
₹8,512.68 Cr
₹2,177.41 Cr
₹313.70 Cr
₹700.57 Cr
₹41.59 Cr
43.87%
High
₹97.45 - 212.98
₹1.00
45,31,63,746
NSE: MARKSANS, BSE: 524404
Mumbai, Maharashtra
www.marksanspharma.com
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic... hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India. Read more
Stocks 
Marksans Pharma Ltd.
Widely used:
